June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Genome wide association study of neuropathic ocular pain
Author Affiliations & Notes
  • Jaxon Huang
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Surgical Services, Miami Veterans Affairs Medical Center, Miami, Florida, United States
  • Daniel Rodriquez
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Susan Slifer
    John P Hussman Institute for Human Genomics, Miami, Florida, United States
  • Eden Martin
    John P Hussman Institute for Human Genomics, Miami, Florida, United States
    Dr John T Macdonald Foundation, Coral Gables, Florida, United States
  • Roy Levitt
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    John P Hussman Institute for Human Genomics, Miami, Florida, United States
  • Anat Galor
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Surgical Services, Miami Veterans Affairs Medical Center, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Jaxon Huang None; Daniel Rodriquez None; Susan Slifer None; Eden Martin None; Roy Levitt None; Anat Galor None
  • Footnotes
    Support  Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&D (CSRD) I01 CX002015 (Dr. Galor), Biomedical Laboratory R&D (BLRD) Service I01 BX004893 (Dr. Galor), Rehabilitation R&D (RRD) I21 RX003883 (Dr. Galor), Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20-1-0579 (Dr. Galor), Department of Defense Vision Research Program (VRP) W81XWH-20-1-0820 (Dr. Galor), National Eye Institute R01EY026174 (Dr. Galor) and R61EY032468 (Dr. Galor), NIH Center Core Grant P30EY014801 (institutional) and Research to Prevent Blindness Unrestricted Grant GR004596 (institutional).
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2776. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jaxon Huang, Daniel Rodriquez, Susan Slifer, Eden Martin, Roy Levitt, Anat Galor; Genome wide association study of neuropathic ocular pain. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2776.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There is evidence suggesting an underlying genetic contribution in chronic pain conditions, as well as the co-existence of these conditions with neuropathic ocular pain (NOP). Therefore, it is possible that there are genomic variants that may predispose an individual for NOP development. We conducted a genome wide association study (GWAS) on individuals with NOP symptoms to identify genomic patterns.

Methods : A total of 329 patients from the Miami Veterans Affairs (VA) eye clinic were recruited. The Neuropathic Pain Symptom Inventory modified for the eye (NPSI-E; range 0-100) was completed for each patient to calculate a NPSI-E-sub-score (summed ratings of burning and wind sensitivity) as an indicator of NOP severity. A GWAS was performed for the NPSI-E-sub-score with a significance threshold of p<5x10-8. A gene-based analyses was performed using the multi-marker analysis of genomic annotation (MAGMA) software (in the Functional Mapping and Annotation (FUMA) online platform). Input SNPs from our GWAS analysis were mapped to 10834 protein coding genes, and significant genes were run through gene set enrichment analysis (GSEA).

Results : 171 single nucleotide polymorphisms (SNPs) reached a threshold of p<10-5, of which 10 SNPs reached the suggestive level of significance of p<5x10-7 and 1 SNP met our genome wide significance threshold. This SNP (P=1.23x10-8) is located on chromosome 11q within an intron of a recently discovered lncRNA. Gene-based analyses demonstrate association with five genes. From GSEA, the top hits were associated with neuronal processes including synapse (false discovery rate (FDR)=6.93x10-17), neurogenesis (FDR=1.97x10-14), neuron development (FDR=2.37x10-14), and neuron differentiation (FDR=3.98x10-13).

Conclusions : Our GWAS and gene-based association tests revealed genes with protein products that may impact morphogenesis and neuronal processes, lending biological plausibility to a potential impact of the enriched SNPs from our GWAS on NOP development. By identifying genetic polymorphisms related to NOP, potential therapeutic targets can be identified for novel treatments.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×